(Q28298876)

14 November 2022

C. D. Pusey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1745027

14 November 2022

A. J. Rees

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1745027

14 November 2022

D. J. Evans

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1745027

14 November 2022

D. K. Peters

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1745027

14 November 2022

C. M. Lockwood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1745027

full work available at URL

14 November 2022

language of work or name

English

0 references

publication date

October 1991

0 references

https://api.elsevier.com/content/article/PII:S0085253815573626?httpAccept=text/xml

1 reference

https://api.elsevier.com/content/article/PII:S0085253815573626?httpAccept=text/plain

14 November 2022

1 reference

Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy

14 November 2022

0 references

0 references

0 references

757-63

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Anti-glomerular basement membrane antibody-induced glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Cyclophosphamide Therapy of Severe Systemic Necrotizing Vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Autoimmunity in rapidly progressive glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Crescentic glomerulonephritis without immune deposits: Clinicopathologic features

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Segmental necrotizing glomerulonephritis: diagnostic, prognostic, and therapeutic significance

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Clinical and pathologic features of polyarteritis nodosa and its renal-limited variant: primary crescentic and necrotizing glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Risk factors in idiopathic renal vasculitis and glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Immunosuppression and the additive effect of plasma exchange in treatment of rapidly progressive glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Treatment and Prognosis of Extracapillary Glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Efficacy of plasma exchange in severe idiopathic rapidly progressive glomerulonephritis. A report of ten cases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Intravenous pulse methylprednisolone therapy of acute crescentic rapidly progressive glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Methylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Improved prognosis of renal microscopic polyarteritis in recent years

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Long-term follow-up of aggressively treated idiopathic rapidly progressive glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Aggressive immunosuppression in glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Therapeutic Plasma Exchange

1 reference

https://api.crossref.org/works/10.1038%2FKI.1991.272

7 January 2021

Autoantibodies to glomerular antigens in patients with Wegener's granulomatosis

1 reference

Vasculitis affecting the kidney: presentation, histopathology and long-term outcome

14 November 2022

1 reference

Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: a report of 43 patients with 51 renal biopsies

14 November 2022

1 reference

Plasma exchange in nephritis

14 November 2022

1 reference